Physicians' Academy for Cardiovascular Education

Agenda Topics ▼Video ▼Online-CME News ▼Meeting Reports Slides ▼About

ACC.19 ▼AHA 2018 ▼Diabetes & CVD ▼EAS 2019 ▼Epigenetics in CVD ▼ESC 2018 ▼Expert Meeting GLP-1, CVD & T2DM ▼HFpEF: The essentials to know ▼Invest in your arteries ▼LDL-c Expert Meeting ▼LDL-c Key Messages ▼PCSK9 ▼

HoFH

Feb. 8, 2014

Share this page with your colleagues and friends:

Continue reading:

5 Things a cardiologist should know about diabetes

Slide Curriculum: Diabetes and cardiology

Slides (curriculum) - July 24, 2018

PACE Special: 5 Things a cardiologist should know about diabetes

Download - Download your free copy

Hypoglycemia in cardiovascular medicine: why worry?

10' education - Mar. 7, 2018 - Prof Guntram Schernthaner - Vienna, Austria - Online CME

ACS

No mortality benefit of beta-blocker in stable CAD beyond one year after MI, according to registry data

Literature - June 24, 2019 - Sorbets E et al., - Eur Heart J. 2019

Benefits of dual COMPASS regimen also seen in patients with moderate renal dysfunction

Literature - May 21, 2019 - Fox KAA et al., - J Am Coll Cardiol. 2019

FDA expands indication for PCSK9 inhibitor to prevent major CV events in adults with CVD

News - May 6, 2019

Atherosclerosis

2019 Anitschkow Award given for defining genetic determinants of plasma lipid levels and CV risk

News - May 27, 2019

Majority of statin-eligible US adults not taking a statin were never offered the therapy

Literature - Apr. 11, 2019 - Bradley CK et al. - J Am Heart Assoc. 2019

Direct Factor Xa inhibitor reduces coronary plaque progression in AF

Literature - Apr. 10, 2019 - Win TT et al. - Am Heart J 2019

Atrial fibrillation

No reduction in mortality and CV outcomes with catheter ablation in AF

Literature - Apr. 2, 2019 - Packer DL, et al. - JAMA 2019

Delayed cardioversion non-inferior to early cardioversion in recent-onset AF

Literature - Apr. 2, 2019 - Pluymaekers NAHA et al. - New Eng J Med 2019

Better outcomes in patients with AF and ACS/PCI with NOAC vs. VKA and when dropping aspirin

3' education - Mar. 17, 2019 - New Orleans, LA, USA - John Alexander, MD

CV Inflammation

High residual inflammatory risk associated with adverse clinical outcomes in patients undergoing PCI with low LDL-c

Literature - June 7, 2019 - Guedeney P et al. - JACC 2019

Effect of IL-1β inhibition on lung cancer sheds new light on the role of inflammation

3' education - May 28, 2019 - EAS 2019, Maastricht - Paul Ridker, MD

Childhood oral infections linked to subclinical carotid atherosclerosis in adulthood

Literature - Apr. 30, 2019 - Pussinen PJ et al. - JAMA Netw Open. 2019

CVRM

No mortality benefit of beta-blocker in stable CAD beyond one year after MI, according to registry data

Literature - June 24, 2019 - Sorbets E et al., - Eur Heart J. 2019

More intelligent intervention through more strategic use of CV biomarkers

3' education - May 28, 2019 - Maastricht, The Netherlands

Novel CVD risk assessment model to assess individual treatment benefit in healthy people

News - June 18, 2019

Diabetes

The future of SGLT2i in HF: Managing patients without TDM?

10' education - June 20, 2019 - ESC HF 2019 - Prof. Adriaan Voors, MD

Real world practices and outcomes in the management of HF in T2DM patients

10' education - June 20, 2019 - ESC HF 2019 - Prof. Carolyn Lam - Singapore

The known and unknown of SGLT2 inhibition in CKD

10' education - June 11, 2019 - ISN-WCN 2019 - Carol Pollock, MD

Familial Hypercholesterolemia

Efforts to move universal cholesterol screening before the age of 20 forward

3' education - May 29, 2019 - Maastricht, The Netherlands - Professor Kausik Ray, MD

Elevated Lp(a) levels and apo(a) production in response to statins

Literature - June 12, 2019 - Tsimikas S et al. - Eur Heart J 2019

Almost 1 in 10 of young adults with MI has clinically defined FH

Literature - June 6, 2019 - Singh A et al., - J Am Coll Cardiol. 2019

GLP-1 RA & CVD

Diabetes, Cardiology & Novel Therapeutic Approaches: Science, Outcomes and Practice

Online-CME - This course consists of 3 lectures

Treatment with GLP-1RA results in reduction of MACE in type 2 diabetes patients with established CVD

Literature - Feb. 12, 2019 - Hernandez AF et al. - The Lancet 2018

Two choices of drugs that reduce CV risk in T2DM

3' education - Feb. 7, 2019 - Prof. John Deanfield, MD

Heart Failure

Expert consensus on clinical practice update on HF

News - June 24, 2019

The future of SGLT2i in HF: Managing patients without TDM?

10' education - June 20, 2019 - ESC HF 2019 - Prof. Adriaan Voors, MD

Real world practices and outcomes in the management of HF in T2DM patients

10' education - June 20, 2019 - ESC HF 2019 - Prof. Carolyn Lam - Singapore

HFpEF: The essentials to know

HFpEF: Current and future clinical approaches to manage HFpEF

10' education - Aug. 27, 2018 - Burkert Pieske, MD - Berlin, Germany

Slides: HFpEF: What are the most likely pathophysiological mechanisms involved in the disease

Slides (presentation) - Aug. 27, 2018 - Carolyn Lam, MD - Singapore

HFpEF: How to diagnose

10' education - Aug. 27, 2018 - Barry Borlaug - Rochester, MN, USA

Hypertension

Use of patiromer results in more patients remaining on spironolactone in resistant hypertension and CKD, with and without HF

News - May 25, 2019

Intensive BP lowering also seems beneficial in adults with diabetes, irrespective of baseline BP

Literature - May 20, 2019 - Rahman F et al. - Hypertension. 2019

Brain aminopeptidase A inhibitor reduces blood pressure in a high-risk diverse population

Literature - May 13, 2019 - Ferdinand KC et al. - Circulation 2019

Inflammation Expert Opinions

Ultime notizie sulla terapia: Un farmaco anti-infiammatorio riduce eventi cardiovascolari maggiori

5' education - Aug. 27, 2017 - ESC 2017, Barcelona, Spain

Breakthrough therapy: Anti-inflammatory drug can affect important CV outcomes

5' education - Aug. 27, 2017 - ESC 2017, Barcelona, Spain

Clinical implications of inhibiting inflammation as risk factor for progression of CVD

5' education - Aug. 27, 2017

Invest in your arteries

Estimating CV risk and treatment benefit

10' education - June 12, 2018 - Prof. Frank Visseren - Utrecht, The Netherlands - Online CME

Importance of hypertension in CVD prevention

10' education - June 12, 2018 - Prof. Richard Hobbs - Oxford, UK - Online CME

The role of lipids in CVD prevention: Lessons learned about statins

10' education - June 6, 2018 - Prof. Kees Hovingh - Amsterdam, The Netherlands - Online CME

Lipids

Non-fasting and fasting lipid levels linked to similar risk of incident CV events

Literature - June 24, 2019 - Mora S et al. - JAMA Intern Med 2019

Postive phase II trial data with novel anti-PCSK9 agent

3' education - May 29, 2019 - Maastricht, The Netherlands - Prof. Evan Stein, MD

Reduced Lp(a) with PCSK9 inhibitors in individuals with high Lp(a) at baseline contributes to CV risk reduction

3' education - May 29, 2019 - Maastricht. The Netherlands - Prof. Chapman, PhD

Lp(a)

Reduced Lp(a) with PCSK9 inhibitors in individuals with high Lp(a) at baseline contributes to CV risk reduction

3' education - May 29, 2019 - Maastricht. The Netherlands - Prof. Chapman, PhD

Elevated Lp(a) levels and apo(a) production in response to statins

Literature - June 12, 2019 - Tsimikas S et al. - Eur Heart J 2019

Debate on Lp(a) – treating high levels or not?

News - May 29, 2019

PCSK9

Postive phase II trial data with novel anti-PCSK9 agent

3' education - May 29, 2019 - Maastricht, The Netherlands - Prof. Evan Stein, MD

Reduced Lp(a) with PCSK9 inhibitors in individuals with high Lp(a) at baseline contributes to CV risk reduction

3' education - May 29, 2019 - Maastricht. The Netherlands - Prof. Chapman, PhD

Elevated Lp(a) levels and apo(a) production in response to statins

Literature - June 12, 2019 - Tsimikas S et al. - Eur Heart J 2019

Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension: Key questions addressed

Online-CME - This course consists of 3 separate lectures

Why cardiologists should be more interested in PAH

3' education - Mar. 9, 2018 - VBWG at ACC, Orlando, FL, USA - Prof. Mardi Gomberg-Maitland, Falls Church, VA, USA

Novel insights in the management and prognosis of pulmonary hypertension

5' education - Aug. 29, 2017 - ESC 2017, Barcelona, Spain - Prof Nazzareno Galiè - Bologna, Italy

Stroke

No reduction of recurrent stroke with DOAC after embolic stroke of undetermined source

Literature - June 12, 2019 - Diener H-C, et al. - N Engl J Med 2019

High residual inflammatory risk associated with adverse clinical outcomes in patients undergoing PCI with low LDL-c

Literature - June 7, 2019 - Guedeney P et al. - JACC 2019

Uninterrupted treatment with NOAC as alternative to VKA for ablation of AF

Literature - June 5, 2019 - Hohnloser SH et al. - Eur Heart J 2019

© 2006 - 2019 pace-cme.org - About